On the public citation graph

A Public Vaccine Development Service: Public Service Logic in the Development of the Oxford Astrazeneca Covid-19 Vaccine

0 signed · 41 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/jrsm.1106openalex-snapshot
Searching for grey literature for systematic reviews: challenges and benefits
inferredcites →https://doi.org/10.1016/j.cpa.2005.09.001openalex-snapshot
TRIPS and the pharmaceutical industry: Prescription for profit?
inferredcites →https://doi.org/10.1016/j.technovation.2003.11.002openalex-snapshot
A system failure framework for innovation policy design
inferredcites →https://doi.org/10.1016/j.technovation.2016.02.004openalex-snapshot
Innovation ecosystems: A critical examination
inferredcites →https://doi.org/10.1016/s0048-7333(99)00055-4openalex-snapshot
The dynamics of innovation: from National Systems and “Mode 2” to a Triple Helix of university–industry–government relations
inferredcites →https://doi.org/10.1016/s0140-6736(02)09096-7openalex-snapshot
Drug development for neglected diseases: a deficient market and a public-health policy failure
inferredcites →https://doi.org/10.1017/9781316809587.009openalex-snapshot
Intellectual Property in Early-Phase Research Public–Private Partnerships in the Biomedical Sector
inferredcites →https://doi.org/10.1017/jme.2021.8openalex-snapshot
A Market Shaping Approach for the Biopharmaceutical Industry: Governing Innovation Towards the Public Interest
inferredcites →https://doi.org/10.1017/s1744137417000479openalex-snapshot
Governing the innovation commons
inferredcites →https://doi.org/10.1038/nrd2131openalex-snapshot
Can open-source R&D reinvigorate drug research?
inferredcites →https://doi.org/10.1038/nrd3654openalex-snapshot
Rare diseases and orphan drugs
inferredcites →https://doi.org/10.1056/nejmcibr2111445openalex-snapshot
In Gratitude for mRNA Vaccines
inferredcites →https://doi.org/10.1080/00076791.2014.975119openalex-snapshot
The evolution of the pharmaceutical industry
inferredcites →https://doi.org/10.1080/01900690903050927openalex-snapshot
The Nature of a Public Service
inferredcites →https://doi.org/10.1080/08911916.2018.1549842openalex-snapshot
Financialized Corporations in a National Innovation System: The U.S. Pharmaceutical Industry
inferredcites →https://doi.org/10.1080/09585192.2011.622918openalex-snapshot
The state and industrial policy in Ireland: a case study of the Irish pharmaceutical sector
inferredcites →https://doi.org/10.1080/13662716.2016.1146124openalex-snapshot
From market fixing to market-creating: a new framework for innovation policy
inferredcites →https://doi.org/10.1080/14719037.2010.488860openalex-snapshot
Public–Private Partnerships in Health Services Delivery
inferredcites →https://doi.org/10.1080/14719037.2012.748820openalex-snapshot
Lean: A failed theory for public services?
inferredcites →https://doi.org/10.1080/17487870.2018.1509712openalex-snapshot
Rethinking value in health innovation: from mystifications towards prescriptions
inferredcites →https://doi.org/10.1080/17487870.2022.2053537openalex-snapshot
Putting value creation back into “public value”: from market-fixing to market-shaping
inferredcites →https://doi.org/10.1093/acprof:oso/9780198747413.003.0009openalex-snapshot
Innovation as Growth Policy
inferredcites →https://doi.org/10.1093/oxrep/graa031openalex-snapshot
COVID-19 and public-sector capacity
inferredcites →https://doi.org/10.1136/bmj.h5542openalex-snapshot
Why the drug development pipeline is not delivering better medicines
inferredcites →https://doi.org/10.1136/bmj.m769openalex-snapshot
Is it time to nationalise the pharmaceutical industry?
inferredcites →https://doi.org/10.1136/bmj.o2592openalex-snapshot
AstraZeneca’s covid-19 (mis)adventure and the future of vaccine equity
inferredcites →https://doi.org/10.1177/01410768211053006openalex-snapshot
The costs of coronavirus vaccines and their pricing
inferredcites →https://doi.org/10.1177/0275074012466935openalex-snapshot
A New Theory for Public Service Management? Toward a (Public) Service-Dominant Approach
inferredcites →https://doi.org/10.1503/cmaj.081429openalex-snapshot
Policy alternatives for treatments for rare diseases
inferredcites →https://doi.org/10.1525/9780520388727openalex-snapshot
Capitalizing a Cure
inferredcites →https://doi.org/10.17863/cam.13671openalex-snapshot
The Financialization of a Cure: A Political Economy of Biomedical Innovation, Pricing, and Public Health
inferredcites →https://doi.org/10.2139/ssrn.2742164openalex-snapshot
Innovation as Growth Policy: The Challenge for Europe
inferredcites →https://doi.org/10.2307/41166446openalex-snapshot
Service Blueprinting: A Practical Technique for Service Innovation
inferredcites →https://doi.org/10.3390/ijerph21010004openalex-snapshot
What Can Public Health Administration Learn from the Decision-Making Processes during COVID-19?
inferredcites →https://doi.org/10.3390/vaccines11030682openalex-snapshot
SARS-CoV-2 Vaccines, Vaccine Development Technologies, and Significant Efforts in Vaccine Development during the Pandemic: The Lessons Learned Might Help to Fight against the Next Pandemic
inferredcites →https://doi.org/10.4324/9781003009153openalex-snapshot
Public Service Logic
inferredcites →https://doi.org/10.4324/9781315685397-8openalex-snapshot
US Pharma's Business Model
inferredcites →https://doi.org/10.4337/9781802205954.00017openalex-snapshot
Public Service Logic: a service lens on the COVID-19 vaccination programmes
inferredcites →https://doi.org/10.5840/thought19563117openalex-snapshot
Science and Christian Belief
inferredcites →https://doi.org/10.7312/noma18050-009openalex-snapshot
9. Varieties of Industrial Policy: Models, Packages, and Transformation Cycles
inferredcites →https://doi.org/10.7759/cureus.16635openalex-snapshot
Vaccine Development Throughout History
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.